Retinoblastoma is a cancer of the eye that affects children from birth through age five. It is usually highly curable. Our goal at Monroe Carell is to provide the best option for your child to achieve health with preservation of vision and minimal effects of treatment. Our team of experts develops an individualized plan for each child to meet this goal.
Meet Your Care Team
- Division of Pediatric Hematology/Oncology, General Hematology and Oncology, Leukemia and Lymphoma, Pediatric Hematology/Oncology, Solid Organ Malignancies
Why Choose Retinoblastoma Care at Children’s Hospital
- Exclusive care
We are the only program in Tennessee that offers all therapies possible for retinoblastoma, including surgery, local eye therapies, systemic chemotherapy, intra-arterial chemotherapy or chemotherapy delivered to the tumor in the eye.
- Collaborative care
- Whole-child care
- Innovative research
In collaboration with the Vanderbilt-Ingram Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute, we have a robust research program in retinoblastoma where we are studying the biology and genetics of the tumor and new therapies to treat the disease.
Carly-Faith's Retinoblastoma Story
Tests, Treatments and Services
We offer a full range of tests, treatments and services, including:
- Laser, cryotherapy, and thermotherapy
- Radiation therapy
- Systemic (intravenous) chemotherapy